Health Care: Drugs

Dr Reddy Laboratories Ltd (RDY: NYSE)

$55.95 n/a | n/a%
07/02/15 - 04:02 PM ET
Company Income Statement
Mar 2015 Mar 2014 Mar 2013 Mar 2012
Sales 2.37B 2.21B 2.14B 1.90B
Cost of Sales 874.43M 823.18M 921.54M 751.34M
Gross Operating Profit 1.50B 1.39B 1.22B 1.15B
Selling, General, and Administrative Expenses 680.93M 648.06M 617.27M 567.49M
Research & Development 279.01M 207.24M 141.05M 116.20M
Operating Income before D & A (EBITDA) 535.17M 530.07M 457.11M 466.70M
Depreciation & Amortization 129.52M 118.74M 101.99M 102.48M
Interest Income 16.97M 27.97M 27.17M 24.12M
Other Income - Net 42.05M 0.00 0.00 15.04M
Special Income / Charges 0.00 23.66M 32.92M -20.45M
Total Income Before Interest Expenses (EBIT) 467.79M 465.87M 417.12M 383.99M
Interest Expense 17.46M 21.29M 18.71M 20.98M
Pre-Tax Income 450.33M 444.59M 398.40M 363.02M
Income Taxes 95.68M 85.12M 90.06M 82.65M
Minority Interest 0.00 0.00 -18.38K 0.00
Net Income From Continuing Operations 354.64M 359.47M 308.34M 280.37M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 354.64M 359.47M 308.34M 280.37M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 354.64M 359.47M 308.36M 280.37M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
354.64M 335.80M 275.42M 300.82M
Preferred Dividends
Net Income Available To Common 354.64M 359.47M 308.34M 280.37M
Basic EPS from Continuing Ops. 2.08 2.11 1.82 1.65
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.08 2.11 1.82 1.65
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.08 2.11 1.82 1.65
Basic Normalized Net Income/Share 2.08 1.97 1.62 1.78
EPS fr Continuing Ops. 2.07 2.11 1.81 1.65
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.07 2.11 1.81 1.65
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.07 2.11 1.81 1.65
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.07 1.97 1.62 1.77
Dividends Paid per Share 0.29 0.26 0.23 0.23

Portfolios with RDY

Latest RDY Headlines from TheStreet

More Financial News for RDY

Press Releases for RDY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter